Last reviewed · How we verify
NCT03151070: QVLM
Scaling Up an Integrated Approach to Improve Delivery Care in North Guatemala With Stepped Wedge Design
trial testing QVLM Intervention package in Maternal Sepsis During Labor in 32,000 participants. Completed in 15 March 2017.
15 March 2017
Quick facts
| Lead sponsor | Hospital San Juan de Dios Guatemala |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 32,000 |
| Start date | 15 December 2013 |
| Primary completion | 15 March 2017 |
| Estimated completion | 15 March 2017 |
Drugs / interventions tested
- QVLM Intervention package
Conditions studied
- Maternal Sepsis During Labor — all drugs for Maternal Sepsis During Labor →
- Hemorrhage, Postpartum — all drugs for Hemorrhage, Postpartum →
- Eclampsia; Complicating Pregnancy — all drugs for Eclampsia; Complicating Pregnancy →
- Pre-Eclampsia — all drugs for Pre-Eclampsia →
Sponsor
Hospital San Juan de Dios Guatemala
Who can join
Eligibility, any sex, with Maternal Sepsis During Labor or Hemorrhage, Postpartum. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
"¡Que Vivan las Madres!: Venga a tener su parto al CAP" (QVLM) is a guatemalan quasi-experimental study that has been performed from January 2014 to January 2017 by the Epidemiological Research Center in Sexual and Reproductive Health (CIESAR) in Guatemala in coordination with PRONTO International and University of San Francisco, California. This project has been financed by Grands Challenges Canada' "Save Lives at Birth, A Grand Challenge for Development" partnership that includes USAID, Norwegian ministry of foreign affairs, Bill\&Melinda Gates foundation, UKaid. This project has applied a stepped wedge design (SWD) over 6 zones or clusters. Each one of the zones contains from 4 to 6 communities, each one with the presence of one second level health facility (known in Spanish as CAP, Centro de Atención Permanente). These health centers are the next level in attention after home, traditional and empirical attention. Communities around the selected health centers are mostly rural and have the worst maternal health indicators in the country. These health centers are expected to have enough equipment and personnel to attend the deliveries that occur in their communities. This study was performed in Huehuetenango and Alta Verapaz districts in north Guatemala. Each one with 3 zones for a total of 6 zones. The study follows a Stepped Wedge Design, in which all 6 zones are eventually intervened, but at different regular periods of time (each period is 4 months long). This project applies a package of 3 simultaneous interventions in each zone with the purpose of increasing institutional deliveries and improving deliveries attention in public health centers. This intervention plan has been implemented in a pilot study reported in (Kestler et. al, 2013).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Ethical issues in the design and conduct of stepped-wedge cluster randomized trials in low-resource settings.
Joag K, Ambrosio G, Kestler E, Weijer C, et al · · 2019 · cited 14× · PMID 31852547 · DOI 10.1186/s13063-019-3842-1
Verify or expand the search:
- PubMed search for NCT03151070
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03151070 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital San Juan de Dios Guatemala
- Last refreshed: 12 May 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03151070.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing